Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer. | Biomed Res Int | 2022 | 35547358 | PubTator, text mining | PubMed |
| Heterogeneous genetic landscape of congenital neutropenia in Korean patients revealed by whole exome sequencing: genetic, phenotypic and histologic correlations. | Sci Rep | 2022 | 35525891 | PubTator, text mining | PubMed |
| Sex-specific extracellular matrix remodeling during early adipogenic differentiation by gestational bisphenol A exposure. | Chemosphere | 2022 | 35504463 | PubTator, text mining | PubMed |
| Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways. | NPJ Syst Biol Appl | 2022 | 35501398 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment. | Front Oncol | 2022 | 35463320 | PubTator, text mining | PubMed |
| Black Tea Reduces Diet-Induced Obesity in Mice via Modulation of Gut Microbiota and Gene Expression in Host Tissues. | Nutrients | 2022 | 35458198 | PubTator, text mining | PubMed |
| The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies. | Cancers (Basel) | 2022 | 35454943 | PubTator, text mining | PubMed |
| Effects of Quercitrin on PRV-Induced Secretion of Reactive Oxygen Species and Prediction of lncRNA Regulatory Targets in 3D4/2 Cells. | Antioxidants (Basel) | 2022 | 35453316 | PubTator, text mining | PubMed |
| EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli. | Cell Death Dis | 2022 | 35428350 | PubTator, text mining | PubMed |
| Multiple idiopathic external cervical root resorption in patient treated continuously with denosumab: a case report. | BMC Oral Health | 2022 | 35428235 | PubTator, text mining | PubMed |
| The Combined Use of Orf Virus and PAK4 Inhibitor Exerts Anti-tumor Effect in Breast Cancer. | Front Microbiol | 2022 | 35401439 | PubTator, text mining | PubMed |
| The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling. | Sci Adv | 2022 | 35394843 | PubTator, text mining | PubMed |
| Identification of potential target genes in Homo sapiens, by miRNA of Triticum aestivum: A cross kingdom computational approach. | Noncoding RNA Res | 2022 | 35387280 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| Association of tumor necrosis factor alpha -308 single nucleotide polymorphism with SARS CoV-2 infection in an Iraqi Kurdish population. | J Clin Lab Anal | 2022 | 35373411 | PubTator, text mining | PubMed |
| Multimodality Treatment of Pulmonary Sarcomatoid Carcinoma: A Review of Current State of Art. | J Oncol | 2022 | 35368903 | PubTator, text mining | PubMed |
| Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling. | Front Oncol | 2022 | 35359365 | PubTator, text mining | PubMed |
| Atypical Lung Carcinoid With EML4/ALK Fusion Detected With Circulating Tumor DNA. | Cureus | 2022 | 35350512 | PubTator, text mining | PubMed |
| Cytotoxic and Radiosensitising Effects of a Novel Thioredoxin Reductase Inhibitor in Brain Cancers. | Mol Neurobiol | 2022 | 35344158 | PubTator, text mining | PubMed |
| Alternative Splicing: A New Therapeutic Target for Ovarian Cancer. | Technol Cancer Res Treat | 2022 | 35343831 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=18